Page 82 - CPG มะเร็งปากมดลูก
P. 82
76 แนวทางการป?องกนั และรกั ษามะเร็งปากมดลกู
เอกสารอา? งอิง
1. Vicharn Lorvidhaya, Imjai Chitapanarux, Supatra Sangruchi, Prasert Lertsanguansinchai, Yongyut Kongthanarat, Saipin
Tangkaratt, et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of
the cervix: a randomized trial. 2003 Apr 1;55(5):1226–32.
2. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy
compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999; 340(15):1137-43.
3. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of
fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix
with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin
Oncol. 1999; 17(5):1339-48.
4. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and
chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999; 340(15):1144–53.
5. Thomas GM. Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. N Engl J Med.
1999; 340(15):1198-200.
6. Rose PG. Combination therapy: New treatment paradigm for locally advanced cervical cancer? Nat Rev Clin Oncol.
2011; 8(7):388-90.
7. Monk BJ, Tewari KS, Koh W-J. Multimodality therapy for locally advanced cervical carcinoma: state of the art and
future directions. J Clin Oncol. 2007; 25(20):2952-65.
8. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines: Cervical cancer version 2.2024.
Available at https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf URL. Accessed: March 13, 2024.
9. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant
hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med.
1999;340(15):1154–61.
10. Peters WA, 3rd, Liu PY, Barrett RJ, 2nd et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation
therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606–13.
11. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for
cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;
26(35):5802–12.
12. Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, et al. ACR Appropriateness Criteria? on Advanced
Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. Int J Radiat Oncol Biol Phys. 2011; 81(3):609-14.
13. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol
1992;25(4):273–9.
14. Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, et al. Overall treatment time in advanced cervical carcinomas: a critical
parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993;27(5):1051–6.
15. Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix
treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993;25(3):391–7.
16. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and
timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys [Internet]. 1995;32(5):1275–88.
